Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 130.22M P/E - EPS this Y 57.80% Ern Qtrly Grth -
Income -76.14M Forward P/E -4.14 EPS next Y 27.10% 50D Avg Chg 9.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 30.00%
Dividend N/A Price/Book 0.77 EPS next 5Y - 52W High Chg -46.00%
Recommedations 3.00 Quick Ratio 79.58 Shares Outstanding 62.01M 52W Low Chg 181.00%
Insider Own 13.47% ROA -26.49% Shares Float 14.06M Beta 0.42
Inst Own 72.06% ROE -40.28% Shares Shorted/Prior 874.35K/1.04M Price 2.11
Gross Margin - Profit Margin - Avg. Volume 379,987 Target Price 1.25
Oper. Margin - Earnings Date Nov 6 Volume 1,815,543 Change 0.96%
About Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California. As of August 31, 2023, Pardes Biosciences, Inc. operates as a subsidiary of MediPacific, Inc.

PRDS Chatroom

User Image valorallure Posted - 4 months ago

$KNTE "In our capacity as a stockholder of the Company, we would not vote in favor of any alternative sale, merger or similar transaction involving the Company." I've seen this exact situation previously with $PRDS. This company will be bought out very soon.

User Image TrendyChart Posted - 6 months ago

Upcoming Earnings Report: $PRDS Pardes Biosciences will be reporting on 11/06/2023 at 4:00PM | Are you forecasting positive or negative earnings growth for this stock?

User Image G101SPM Posted - 7 months ago

#TAKEAWAY $PRDS $53.88 +1.23. DAC $54.54 - last $52.70 (9.28.23) EXIT $59.25. RETAIN POSITION. Annual recurring revenue is the key demand metric for PRGS and, in the words of CFO Anthony Folger, provides the best view of its underlying performance. In Q3, ARR increased by 18% on a constant currency basis to $577 mln. The growth essentially matches last quarter's increase of 19% and was supported by a solid retention rate that was just under 101%. On the topic of MarkLogic, PRGS stated that its performing in line with expectations and that the integration of the business is on track to meet the anticipated timeline. The $355 mln deal, which was completed in February 2023, bolstered PRGS's infrastructure software portfolio by adding NoSQL database and semantic metadata management products. note: MarkLogic should add more than $100 mln in annual revenue, contribute strong cash flows, and be accretive to earnings in FY24.

User Image ms101 Posted - 7 months ago

$COCP Finally the true GAME-CHANGER CDI-988 molecule after 3.5 preclinical (Cocrystal is the gold standard in preclinical) which differentiates in ALL the other pre clinical small molecule biotechs who have ALL rushed and failed their COVID drug clinical trials $ENTA $PRDS $AVIR etc. Reminder Fred Hassan who purchased 1M shares, KEY board member and the PHARMA LEGEND and what ever he touches turns to gold. Last one back in April was the Merck M&A $11B $RXDX. Things are going to heat up!!

User Image kuda8 Posted - 7 months ago

$PRDS received my cash minus 15% (i am a french investor) , did the cash was taxed as a dividend ?

User Image risenhoover Posted - 7 months ago

$PRDS / Pardes Biosciences files form 15-12G https://fintel.io/doc/sec-pardes-biosciences-inc-1822711-1512g-2023-september-11-19611-3695?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image LongPlay85 Posted - 7 months ago

$SRNE is it $VDRM or $TOMDF or $PRDS

User Image Ragz2Richz Posted - 7 months ago

$PRDS cash is now available in my account as of this morning. Looking forward to that CVR! The patent is vastly encompassing. I'd be flabbergasted if they don't cash in on it one way or another.

User Image Ragz2Richz Posted - 7 months ago

$PRDS Promptly pay, my ass! Where's my 💰

User Image risenhoover Posted - 08/31/23

$PRDS PRDS / Pardes Biosciences Inc Price Target Updated https://fintel.io/sfo/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image EarningsInsider Posted - 08/31/23

Pardes Biosciences, Inc. Files SEC Form 8-K $PRDS https://www.marketbeat.com/stocks/NASDAQ/PRDS/sec-filings/

User Image Last10K Posted - 08/31/23

$PRDS just filed with the SEC a Change in Assets, a Listing Status, a Security Holders Change, a Change in Control, a Event for Officers, a Bylaw Change and a Financial Exhibit https://last10k.com/sec-filings/PRDS/0001140361-23-041917.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=PRDS

User Image STCKPRO Posted - 08/31/23

$PRDS NEW ARTICLE : Pardes Biosciences Announces Closing of Tender Offer https://www.stck.pro/news/PRDS/60327629/

User Image Stock_Titan Posted - 08/31/23

$PRDS Pardes Biosciences Announces Closing of Tender Offer https://www.stocktitan.net/news/PRDS/pardes-biosciences-announces-closing-of-tender-ajkfo0c2mcdm.html

User Image tradethehalt Posted - 8 months ago

$PRDS trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $2.17 Vol: 2.38M.

User Image otcdynamics Posted - 8 months ago

$PRDS MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences https://www.otcdynamics.com/prds-medipacific-offering-2-13-per-share-plus-one-contingent-value-right-per-share-in-tender-offer-for-pardes-biosciences

User Image risenhoover Posted - 8 months ago

$PRDS / Pardes Biosciences files form SC 13E3/A https://fintel.io/sf/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 8 months ago

$PRDS / Pardes Biosciences files form SC 14D9/A https://fintel.io/sf/us/prds?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image otcdynamics Posted - 8 months ago

$PRDS MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences https://www.otcdynamics.com/prds-medipacific-offering-2-13-per-share-plus-one-contingent-value-right-per-share-in-tender-offer-for-pardes-biosciences

User Image STCKPRO Posted - 8 months ago

$PRDS NEW ARTICLE : MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences https://www.stck.pro/news/PRDS/60075529/

User Image Stonkmoon Posted - 8 months ago

$PRDS 2023-08-28 11:33 ET MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences https://stonkmoon.com/news/PRDS/3bd9410a281d318e2f465b39bc973ef5

User Image Stock_Titan Posted - 8 months ago

$PRDS MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences https://www.stocktitan.net/news/PRDS/medi-pacific-offering-2-13-per-share-plus-one-contingent-value-right-1ceehzjunses.html #offering

User Image otcJUNKeee Posted - 8 months ago

$SNNC the strong mover right now let’s see the others ( $PRDS $NRXS and $CHSN ) follow that lead!

User Image Mergerbrief Posted - 8 months ago

$PRDS MediPacific, Inc. - Tender Offer Expires

User Image otcJUNKeee Posted - 8 months ago

What I’m watching today, $CHSN doesn’t seem to want to stop! $SNNC strong move but at key resistance. $NRXS entering support regions again. $PRDS huge volume Friday, should break resistance soon.

User Image tickeron Posted - 8 months ago

How does this affect your portfolio? $PRDS The volume increased for one day, resulting in a record-breaking daily growth of 779% of the 65-Day Volume Moving Average. View odds of downtrend. https://srnk.us/go/4845272

User Image joe77w Posted - 8 months ago

$PRDS how much could be worth the CVR?

User Image ChartMill Posted - 8 months ago

Our analyzer finds a low risk trade suggestion for $PRDS, buy stop @2.17, stop @2.05!. https://www.chartmill.com/stock/quote/PRDS/technical-analysis?key=b990b948-35f5-4ded-8ac0-012ea975650b&utm_source=TRADINGSETUP&utm_medium=stocktwits&utm_campaign=TA&utm_content=PRDS

User Image tickeron Posted - 8 months ago

Pardes Biosciences to report earnings on August 21, 2023. Earnings per share (EPS) estimate: $-0.24 $PRDS https://srnk.us/go/4838466

User Image ChartMill Posted - 8 months ago

Squeeze play pattern detected by our stock screener for $PRDS, $FREE and $SWIM. https://www.chartmill.com/stock/stock-screener?sid=12&f=sqds,v1_50b300,sl_ti_105_X,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=400&cl=F&o1=0&o2=57&op1=14&op2=20,1.5,10&utm_source=Momentum_Squeeze_Play_Setups&utm_medium=stocktwits&utm_campaign=screen

Analyst Ratings
JMP Securities Market Perform Jul 18, 23
SVB Leerink Market Perform Apr 4, 23
JMP Securities Market Outperform Mar 15, 23
SVB Leerink Outperform Jan 27, 23
JMP Securities Market Outperform Dec 13, 22
SVB Leerink Outperform Aug 16, 22
SVB Leerink Outperform Mar 15, 22
Jefferies Buy Jan 18, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Foresite Capital Opportunity M... 10% Owner 10% Owner Apr 05 Buy 1.50 773,952 1,160,928 8,773,134 04/06/23
Foresite Capital Management V,... 10% Owner 10% Owner Apr 05 Buy 1.50 773,952 1,160,928 13,583,762 04/06/23